Biotechnology Portfolio Biotechnology Fund Quote

FBIOX Fund  USD 17.83  0.25  1.42%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 21

 
High
 
Low
Low
Biotechnology Portfolio is trading at 17.83 as of the 23rd of April 2024; that is 1.42 percent increase since the beginning of the trading day. The fund's open price was 17.58. Biotechnology Portfolio has about a 21 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Biotechnology Portfolio Biotechnology are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of May 2022 and ending today, the 23rd of April 2024. Click here to learn more.
The fund invests primarily in common stocks. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. More on Biotechnology Portfolio Biotechnology

Moving together with Biotechnology Mutual Fund

  0.73FPTKX Fidelity Freedom 2015PairCorr
  0.65FPURX Fidelity PuritanPairCorr
  0.65FPUKX Fidelity PuritanPairCorr
  0.71FPXTX Fidelity PennsylvaniaPairCorr
  0.77FQIFX Fidelity Freedom IndexPairCorr
  0.7FQIPX Fidelity Freedom IndexPairCorr
  0.88FQITX Fidelity Salem StreetPairCorr

Biotechnology Mutual Fund Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biotechnology Portfolio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biotechnology Portfolio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic IdeaMonster Funds (View all Themes)
Fund ConcentrationFidelity Investments Funds, Large Funds, Health Funds, Monster Funds, Health, Fidelity Investments, Large, Health (View all Sectors)
Update Date31st of March 2024
Expense Ratio Date29th of April 2023
Fiscal Year EndFebruary
Biotechnology Portfolio Biotechnology [FBIOX] is traded in USA and was established 23rd of April 2024. Biotechnology Portfolio is listed under Fidelity Investments category by Fama And French industry classification. The fund is listed under Health category and is part of Fidelity Investments family. The entity is thematically classified as Monster Funds. This fund currently has accumulated 4.78 B in assets under management (AUM) with no minimum investment requirementsBiotechnology Portfolio is currently producing year-to-date (YTD) return of 2.77% with the current yeild of 0.0%, while the total return for the last 3 years was -4.76%.
Check Biotechnology Portfolio Probability Of Bankruptcy

Instrument Allocation

Sector Allocation

Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Biotechnology Mutual Fund. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Biotechnology Mutual Fund, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Biotechnology Portfolio Biotechnology Mutual Fund, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.

Top Biotechnology Portfolio Biotechnology Mutual Fund Constituents

VRTXVertex PharmaceuticalsStockHealth Care
SGENSeagen IncStockHealth Care
TGTXTG TherapeuticsStockHealth Care
ACADACADIA PharmaceuticalsStockHealth Care
PTCTPTC TherapeuticsStockHealth Care
INCYIncyteStockHealth Care
REGNRegeneron PharmaceuticalsStockHealth Care
More Details

Biotechnology Portfolio Target Price Odds Analysis

Based on a normal probability distribution, the odds of Biotechnology Portfolio jumping above the current price in 90 days from now is about 92.71%. The Biotechnology Portfolio Biotechnology probability density function shows the probability of Biotechnology Portfolio mutual fund to fall within a particular range of prices over 90 days. Assuming the 90 days horizon the mutual fund has a beta coefficient of 1.4353. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Biotechnology Portfolio will likely underperform. Additionally, biotechnology Portfolio Biotechnology has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 17.83HorizonTargetOdds Above 17.83
7.18%90 days
 17.83 
92.71%
Based on a normal probability distribution, the odds of Biotechnology Portfolio to move above the current price in 90 days from now is about 92.71 (This Biotechnology Portfolio Biotechnology probability density function shows the probability of Biotechnology Mutual Fund to fall within a particular range of prices over 90 days) .

Biotechnology Portfolio Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Biotechnology Portfolio market risk premium is the additional return an investor will receive from holding Biotechnology Portfolio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biotechnology Portfolio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Biotechnology Portfolio's alpha and beta are two of the key measurements used to evaluate Biotechnology Portfolio's performance over the market, the standard measures of volatility play an important role as well.

Biotechnology Portfolio Against Markets

Picking the right benchmark for Biotechnology Portfolio mutual fund is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biotechnology Portfolio mutual fund price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biotechnology Portfolio is critical whether you are bullish or bearish towards Biotechnology Portfolio Biotechnology at a given time. Please also check how Biotechnology Portfolio's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Biotechnology Portfolio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Aroon Oscillator Now

   

Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
All  Next Launch Module

How to buy Biotechnology Mutual Fund?

Before investing in Biotechnology Portfolio, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Biotechnology Portfolio. To buy Biotechnology Portfolio fund, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Biotechnology Portfolio. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Biotechnology Portfolio fund. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Biotechnology Portfolio Biotechnology fund in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Biotechnology Portfolio Biotechnology fund, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the fund
It's important to note that investing in stocks, such as Biotechnology Portfolio Biotechnology, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in fund prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Biotechnology Portfolio Biotechnology?

The danger of trading Biotechnology Portfolio Biotechnology is mainly related to its market volatility and Mutual Fund specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biotechnology Portfolio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biotechnology Portfolio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biotechnology Portfolio is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Biotechnology Portfolio Biotechnology. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Please note, there is a significant difference between Biotechnology Portfolio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotechnology Portfolio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotechnology Portfolio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.